Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 1
1982 1
1983 1
1985 2
1987 2
1988 2
1991 2
1992 2
1993 1
1994 3
1996 1
1998 3
2000 2
2001 2
2002 2
2003 1
2005 1
2007 2
2008 1
2010 1
2011 1
2012 1
2013 1
2014 1
2015 1
2017 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Paraneoplastic manifestations in children.
de Graaf JH, Tamminga RY, Kamps WA. de Graaf JH, et al. Eur J Pediatr. 1994 Nov;153(11):784-91. doi: 10.1007/BF01972883. Eur J Pediatr. 1994. PMID: 7843190 Review.
Paraneoplastic manifestations are signs and symptoms observed in patients with cancer, distant from the tumour or its metastases and not caused by invasion, obstruction or bulk mass. In children with cancer, paraneoplastic manifestations are rare and distinct from those …
Paraneoplastic manifestations are signs and symptoms observed in patients with cancer, distant from the tumour or its metastases and …
VIPoma syndrome.
Krejs GJ. Krejs GJ. Am J Med. 1987 May 29;82(5B):37-48. doi: 10.1016/0002-9343(87)90425-6. Am J Med. 1987. PMID: 3035922 Review.
Since the description of the watery diarrhea syndrome by Verner and Morrison 29 years ago, clinical and experimental observations have elucidated the pathophysiology of this disease. Vasoactive intestinal polypeptide (VIP) is produced and released by a tumor of the pancrea …
Since the description of the watery diarrhea syndrome by Verner and Morrison 29 years ago, clinical and experimental observations hav …
Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs).
Kanakis G, Kaltsas G. Kanakis G, et al. Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):791-802. doi: 10.1016/j.bpg.2012.12.006. Best Pract Res Clin Gastroenterol. 2012. PMID: 23582919 Review.
Biochemical markers are applied in gastroenteropancreatic neuroendocrine tumours (GEP-NETs) for diagnostic, prognostic or predictive purposes. Chromogranin A is the most important general marker and it is recommended to be measured in every patient with a suspected NET, wh …
Biochemical markers are applied in gastroenteropancreatic neuroendocrine tumours (GEP-NETs) for diagnostic, prognostic or predictive …
A clinical analysis on functioning pancreatic neuroendocrine tumors (focusing on VIPomas): a single-center experience.
Murakami M, Fujimori N, Matsumoto K, Ohno A, Teramatsu K, Takamatsu Y, Takeno A, Ueda K, Oono T, Ito T, Ogawa Y. Murakami M, et al. Endocr J. 2022 Oct 28;69(10):1201-1209. doi: 10.1507/endocrj.EJ22-0111. Epub 2022 May 27. Endocr J. 2022. PMID: 35644576 Free article.

The median survival time was significantly shorter for patients with VIPoma than for those with NF-PanNET (5.9 vs. 26.7 years, p < 0.0001), insulinoma (21.8 years, p < 0.0001), and gastrinoma (12.3 years, p = 0.0325). ...VIPomas should be considered in patients with

…
The median survival time was significantly shorter for patients with VIPoma than for those with NF-PanNET (5.9 vs. 26.7 years, p < …
Sunitinib achieved fast and sustained control of VIPoma symptoms.
de Mestier L, Walter T, Brixi H, Lombard-Bohas C, Cadiot G. de Mestier L, et al. Eur J Endocrinol. 2015 Jan;172(1):K1-3. doi: 10.1530/EJE-14-0682. Epub 2014 Oct 10. Eur J Endocrinol. 2015. PMID: 25305306
Two patients with progressive metastatic pancreatic NETs and refractory VIPoma symptoms were treated with sunitinib. This led to fast and sustained total relief of VIPoma symptoms, enabling earlier discharge from hospital and improvement in their quality of life. .. …
Two patients with progressive metastatic pancreatic NETs and refractory VIPoma symptoms were treated with sunitinib. This led to fast …
Primary Pancreatic Secretinoma: Further Evidence Supporting Secretin as a Diarrheogenic Hormone.
Chey WY, Frankel WL, Roy S, Datta S, Sen CK, Dillhoff M, Muscarella P, Soergel KH, Tompkins RK, Chang TM, Bradley EL 3rd, Ellison EC. Chey WY, et al. Ann Surg. 2017 Aug;266(2):346-352. doi: 10.1097/SLA.0000000000001938. Ann Surg. 2017. PMID: 27501174 Free PMC article.
They suggested a secretin-like hormone of islet cell origin explains WDS and achlorhydria. These observations, however, predated radioimmunoassay, immunohistochemical staining, and other molecular studies. ...
They suggested a secretin-like hormone of islet cell origin explains WDS and achlorhydria. These observations, however, predated radi …
Population-based study of islet cell carcinoma.
Yao JC, Eisner MP, Leary C, Dagohoy C, Phan A, Rashid A, Hassan M, Evans DB. Yao JC, et al. Ann Surg Oncol. 2007 Dec;14(12):3492-500. doi: 10.1245/s10434-007-9566-6. Epub 2007 Sep 26. Ann Surg Oncol. 2007. PMID: 17896148 Free PMC article.

By multivariate Cox proportional modeling, stage (P < .001), primary tumor location (P = .04), and age at diagnosis (P < .001) were found to be significant predictors of survival. CONCLUSIONS: Islet cell carcinomas account for approximately 1.3% of cancers arising in

…

By multivariate Cox proportional modeling, stage (P < .001), primary tumor location (P = .04), and age at diagnosis (P < .001) were fo

…
Islet cell tumors of the pancreas: the medical oncologist's perspective.
Brentjens R, Saltz L. Brentjens R, et al. Surg Clin North Am. 2001 Jun;81(3):527-42. doi: 10.1016/s0039-6109(05)70141-9. Surg Clin North Am. 2001. PMID: 11459269 Review.
Management of metastatic disease is conservative. Initial treatment of these tumors includes expectant observation and medical management of symptoms with clinical monitoring and serial CT scans to assess tumor growth. ...
Management of metastatic disease is conservative. Initial treatment of these tumors includes expectant observation and medical manage …
Neuroendocrine tumours--analysis of own material--a nine--year retrospective study.
Kaliszewski K, Bednarz W, Łukieńczuk T, Balcerzak W, Kaliszewska M, Dawiskiba J. Kaliszewski K, et al. Hepatogastroenterology. 2010 Mar-Apr;57(98):236-41. Hepatogastroenterology. 2010. PMID: 20583420
All cases were subjected to surgical procedure with an aim to resect the tumour completely. RESULTS: In the present study were observed 6 cases of carcinoids localized in ileum, cecum and sigmoid colon, 1 case of gastrinoma in pancreatic head localization, 1 case of insuli …
All cases were subjected to surgical procedure with an aim to resect the tumour completely. RESULTS: In the present study were observed …
Sunitinib for the treatment of metastatic paraganglioma and vasoactive intestinal polypeptide-producing tumor (VIPoma).
Bourcier ME, Vinik AI. Bourcier ME, et al. Pancreas. 2013 Mar;42(2):348-52. doi: 10.1097/MPA.0b013e31825c53fa. Pancreas. 2013. PMID: 23407483
METHODS: The patients were a 12-year-old boy with metastatic vasoactive intestinal polypeptide-producing tumor (VIPoma) and a 70-year-old woman with metastatic paraganglioma/NET. ...In both patients, improvements were observed in biochemical tumor markers, clinical …
METHODS: The patients were a 12-year-old boy with metastatic vasoactive intestinal polypeptide-producing tumor (VIPoma) and a 70-year …
42 results